STRYKER CORP SYK
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
4/9
Piotroski F — financial health
3.96
Altman Z″ — distress risk · safe
39.6%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $25.1B | $3.2B | $16.1B | $4.3B | $22.4B |
| 2024 | $22.6B | $3.0B | $14.4B | $3.5B | $20.6B |
| 2023 | $20.5B | $3.2B | $13.1B | $3.1B | $18.6B |
| 2022 | $18.4B | $2.4B | $11.6B | $2.0B | $16.6B |
| 2021 | $17.1B | $2.0B | $11.0B | $2.7B | $14.9B |
| 2020 | $14.4B | $1.6B | $9.1B | $2.8B | $13.1B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Stiles Spencer S | President and COO | 2026-06-01 | Gift | 1,607 | — |
| Fletcher Robert S | VP, Chief Legal Officer | 2026-05-28 | Sell | 165 | $305.66 |
| Fletcher Robert S | VP, Chief Legal Officer | 2026-05-28 | Sell | 2,809 | $306.56 |
| Fletcher Robert S | VP, Chief Legal Officer | 2026-05-28 | Sell | 1,067 | $307.30 |
| Fletcher Robert S | VP, Chief Legal Officer | 2026-05-28 | Sell | 258 | $308.79 |
| Fletcher Robert S | VP, Chief Legal Officer | 2026-05-28 | Sell | 125 | $310.22 |
| Fletcher Robert S | VP, Chief Legal Officer | 2026-05-28 | Sell | 120 | $304.23 |
| STRYKER RONDA E | director | 2026-05-26 | Sell | 21,807 | $310.77 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.96 (safe)
- Working capital / assets 0.145
- Retained earnings / assets 0.428
- EBIT / assets 0.102
- Equity / liabilities 0.882
Source: SEC EDGAR filings · CIK 0000310764 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.